Toshiharu Ninomiya

Title: Toshiharu Ninomiya: Innovator in Disease Risk Assessment

Introduction

Toshiharu Ninomiya is a notable inventor based in Japan. He has made significant contributions to the field of health and disease prevention. His work primarily focuses on assessing the risk of diseases such as dementia and cardiovascular conditions.

Latest Patents

Ninomiya's latest patents include a Disease Risk Assessment Apparatus and a Disease Risk Assessment Method, Program, and Food for Dementia Prevention. This apparatus assesses the risk of developing dementia based on the concentration of specific amino acids in the blood. The amino acids involved include histidine, phenylalanine, leucine, isoleucine, methionine, threonine, glycine, glutamine, lysine, asparagine, homocysteine, cystathionine, S-adenosylmethionine, and S-adenosylhomocysteine. Another significant invention is a Cardiovascular Disease Primary Prevention Agent for patients with high blood levels of high-sensitivity C-reactive protein. This agent aims to lower the risk of cardiovascular disease in subjects with elevated hs-CRP levels, even if they have no prior history of cardiovascular issues.

Career Highlights

Throughout his career, Ninomiya has worked with esteemed institutions such as Kyushu University and Kurume Research Park Co., Ltd. His research has focused on innovative methods to assess and prevent diseases, showcasing his commitment to improving public health.

Collaborations

Ninomiya has collaborated with various professionals in his field, including Yutaka Kiyohara. These collaborations have contributed to the advancement of his research and inventions.

Conclusion

Toshiharu Ninomiya is a dedicated inventor whose work in disease risk assessment has the potential to significantly impact health outcomes. His innovative approaches to understanding and preventing diseases highlight the importance of research in public health.